Home › Funds › PURA VIDA INVESTMENTS, LLC › MGX

PURA VIDA INVESTMENTS, LLC position in MGX

METAGENOMI THERAPEUTICS INC · Health Care

PURA VIDA INVESTMENTS, LLC reported holding 264,391 shares of MGX (METAGENOMI THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$315K, representing 0.85% of its reported portfolio and ranking #16 among its reported holdings. PURA VIDA INVESTMENTS, LLC has disclosed MGX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)264.39K sh
Reported value held$314.62K
Portfolio Weight0.85%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PURA VIDA INVESTMENTS, LLC's MGX position evolved

PURA VIDA INVESTMENTS, LLC first disclosed a stake in MGX in Q1 2024 at 461,283 shares (US$4.9M). Across 10 filings, PURA VIDA INVESTMENTS, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 264,391 shares valued at US$315K. Notable position changes include a 41% trim in Q2 2024 (shares fell 12% over the following quarter), a 260% increase in Q2 2025 (shares rose 60% over the following quarter), a 72% trim in Q3 2025 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 461.28K $4.87M New
Q2 2024 270.62K $1.04M Reduce
Q3 2024 270.62K $587.24K Hold
Q4 2024 264.39K $954.45K Reduce
Q1 2025 264.39K $359.57K Hold
Q2 2025 952.13K $391.30K Add
Q3 2025 264.39K $626.61K Reduce
Q4 2025 264.39K $428.31K Hold
Q1 2026 264.39K $354.28K Hold
Q2 2026 264.39K $314.62K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MGX and 13F data

MGX (METAGENOMI THERAPEUTICS INC) is a Health Care company. 23 other funds we track also report a position in MGX — the largest reported positions include Catalio Capital Management, LP (US$630K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MGX

All MGX fund holders →

FAQ

How long has PURA VIDA INVESTMENTS, LLC held MGX?

PURA VIDA INVESTMENTS, LLC has disclosed MGX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is PURA VIDA INVESTMENTS, LLC's current position in MGX?

As of Q2 2026, PURA VIDA INVESTMENTS, LLC holds 264.39K shares of MGX (METAGENOMI THERAPEUTICS INC), valued at $314.62K, representing 0.85% of its reported portfolio and ranking #16.

Has PURA VIDA INVESTMENTS, LLC been buying or selling MGX?

In the latest 13F filing (Q2 2026), PURA VIDA INVESTMENTS, LLC held unchanged its position in MGX.

Which other funds hold MGX?

Other major institutional holders of MGX include Catalio Capital Management, LP, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.